Ghani S, Sochat M, Luo J, et al. - Management strategies for male triple negative breast cancer (TNBC) are typically based off research conducted in female TNBC patients. Researchers conducted this retrospective cohort study investigating risk factors for developing these malignancies, the optimal treatment approach, and both short‐term and long‐term outcomes. Data from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program yielded data of 66 male patients diagnosed with TNBC between 2010 and 2016. Analysis suggest that, similar to population studies of women with TNBC, tumor stage is a major prognostic factor of OS in men with TNBC. Further, the data indicated the likely significance of employing surgical treatment strategy, with improved OS being observed with total mastectomies over partial mastectomies. They also indicated a likely role of other variables such as tumor grade and T stage, but these did not attain statistical significance owing to the small population size.